The aim of the Education Committee (EC) is to coordinate ESOT’s efforts to advance multidisciplinary education for transplant professionals at all career levels and to contribute to their professional development.
The Basic Science Committee promotes scientific issues and transplantation research within ESOT. An active basic science community and an efficient translation of innovation into the clinic are crucial for the future of transplantation medicine.
The European Transplant Allied Healthcare Professionals (ETAHP) reaches out to allied healthcare professionals throughout Europe in order to ensure the best care possible for all transplant patients, with the aim to optimize patient outcomes.
The Young Professionals in Transplantation (YPT) is the Network for Junior Transplant professionals of ESOT, representing all young transplant clinicians and scientists who are beginning a career in transplantation and organ donation.
The mission of ECTORS is to provide a forum for discussing and stimulating novel developments in the fields of cellular therapies in organ transplantation, organ regeneration and generation of new organs from stem cells and biomaterials.
ECTTA is the forum for experience exchange on treatment of patients with end-stage heart and lung failure. Our aim is to improve outcomes for the patients.
EDTCO aims to support health care professionals to provide clinically effective programmes on organ and tissue donation, procurement and transplantation.
EKITA is the Organ Expert Section of ESOT on kidney transplantation in Europe, providing a forum for kidney transplantation professionals to exchange scientific information and views aimed at providing the best service to European patients .
The European Liver and Intestine Transplant Association (ELITA), previously known as the European Liver Transplant Association (ELTA), is a section of ESOT. Its membership represents the expertise on liver and intestinal transplantation in Europe.
ELPAT is a European platform that brings continuity and progress in European research and dialogue on "Ethical, Legal and Psychosocial Aspects of organ Transplantation". ELPAT currently consists of over 160 experts from more than 25 European countries.
EPITA is established to provide a forum for those working in the field of pancreas and islet of Langerhans transplantation or any other alternative form of beta cell replacement in Europe, to exchange scientific information and views related primarily to providing the best service for patients in Europe requiring pancreas or islet transplantation.
VCA has opened a new era in the field of transplantation, reconstructive and restorative surgery. This Section brings together 10 representatives of major European teams at the forefront in this field.
Dear Colleagues and friends, With profound sadness that we announce the passing of our esteemed colleague and ECTORS board member, Bojan Vrtovec, who left us far too soon on January 12 at the age of 52. Bojan served as Chief of Cardiology and Medical Director of the Advanced Heart Failure and Transplantation Program at Ljubljana
This webinar will feature leading experts and patient voices who will delve into the scientific, clinical, and human aspects of desensitisation. Attendees will gain a comprehensive understanding of HLA sensitisation, learn to identify which patients could benefit from desensitisation protocols, and hear firsthand experiences of patients navigating this complex journey. A unique dialogue between a
ESOT is proud to have participated in the Santander Global Summit in Transplantation that took place in Spain in November 2023. The Summit was organised by the Organización Nacional de Trasplantes (ONT) under the Spanish Presidency of the Council of the European Union and co-organised with the EDQM-Council of Europe, The Transplantation Society (TTS) and
Sponsored by Biotest, the highly anticipated third module of the Management of CMV in Solid Organ Transplant Patients course is now open for registration. Titled The Future of CMV Management, this module promises cutting-edge insights into advancements in CMV immunotherapy and vaccination for transplant patients. Learning Objectives Participants will: Explore the evolving landscape of CMV
The ESOT Basic Science Webinar series has resumed after a brief break, kicking off with “Xenotransplantation: The Future is Now – Past, Present, and Future Challenges.” The session covered advancements and the translation of cutting-edge transplant science, focusing on recent breakthroughs and ongoing challenges in xenotransplantation. The distinguished international panel featured experts in the field:
We are pleased to announce an upcoming webinar that will explore the groundbreaking field of RNA interference and its transformative potential in the realm of transplantation. The webinar is set to offer an insight starting from biological concepts and moving towards innovative clinical uses that are revolutionising the landscape of patient treatment. Scheduled for 12
This comprehensive course is composed of three modules that will be released regularly over the next few weeks. These resources are available for free on Transplant Live for all ESOT members.
Improving transplant patient outcomes is at the forefront of our mission and, we are eager to collaborate with research teams who share the common goal of improving the lives of those hindered by inequitable access to life-changing treatments and procedures. Here’s why our involvement can be a game-changer for your project: Unmatched Expertise: With a
This course helps learners understand and personalise different induction regimens, including their range, benefits, and consequences.
Designed by #ESOTeducation with Luca Toti & Raj Thuraisingham and kindly supported by Sanofi
The latest issue of Transplant International features a multicentre Spanish study in which sex-related inequities in access to liver transplantation were investigated. Of 14,385 patients analysed, women were less likely to receive a transplant than men and had a longer time on the waiting list. In addition, there was a trend towards a higher risk
